Board approves INR 430 crore NCD issuance via private placement
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Krsnaa Diagnostics board on Dec 12, 2025 approved issuing up to INR 430 crore of secured, unlisted, redeemable NCDs via private placement. The issue comprises 43,000 NCDs at INR 1 lakh face value, with a 7-year tenure. Coupon rate is fixed (rate not disclosed). Principal and interest are payable half-yearly, with redemption in 13 equal installments starting 6 months from allotment. NCDs will be secured by a charge over identified company assets.
Company raising INR 430 crore debt may pressure margins via finance costs. No equity dilution, but identified assets are pledged as security.